321 related articles for article (PubMed ID: 3035114)
21. [Possibility of using 131I-meta-iodobenzylguanidine in the diagnosis of neuroendocrine tumors differing from pheochromocytomas].
Troncone L; Rufini V; Maini CL; Valenza V; Danza FM; Lasorella A
Radiol Med; 1986 Dec; 72(12):963-8. PubMed ID: 3797720
[TBL] [Abstract][Full Text] [Related]
22. [Scintigraphy with iodine-131 metaiodobenzylguanidine in the study of paraganglioma. Comparison between benign and malignant tumors].
Maurea S; Cuocolo A; Reynolds J; Keiser H; Neumann R; Salvatore M
Radiol Med; 1994 May; 87(5):688-93. PubMed ID: 8008902
[TBL] [Abstract][Full Text] [Related]
23. Use of 131I-MIBG scintigraphy in the evaluation of suspected pheochromocytoma.
Swensen SJ; Brown ML; Sheps SG; Sizemore GW; Gharib H; Grant CS; van Heerden JA
Mayo Clin Proc; 1985 May; 60(5):299-304. PubMed ID: 3990377
[TBL] [Abstract][Full Text] [Related]
24. Successful and unsuccessful approaches to imaging carcinoids: comparison of a radiolabelled tryptophan hydroxylase inhibitor with a tracer of biogenic amine uptake and storage, and a somatostatin analogue.
Macfarlane D; Gonin J; Wieland D; Mangner T; Froelich J; Beierwaltes W; Shapiro B
Eur J Nucl Med; 1996 Feb; 23(2):131-40. PubMed ID: 8925846
[TBL] [Abstract][Full Text] [Related]
25. Carcinoid tumors: iodine-131 MIBG scintigraphy.
Hanson MW; Feldman JM; Blinder RA; Moore JO; Coleman RE
Radiology; 1989 Sep; 172(3):699-703. PubMed ID: 2772175
[TBL] [Abstract][Full Text] [Related]
26. [Diagnosis of pheochromocytoma by 131I-MIBG scintigraphy].
Miyanaga N; Hattori K; Shiraiwa H; Hinotsu S; Nemoto R; Koiso K; Takeda T; Ishikawa N
Hinyokika Kiyo; 1990 Feb; 36(2):105-8. PubMed ID: 2343801
[TBL] [Abstract][Full Text] [Related]
27. Iodine-123-metaiodobenzylguanidine scintigraphy in patients with chemodectomas of the head and neck region.
van Gils AP; van der Mey AG; Hoogma RP; Falke TH; Moolenaar AJ; Pauwels EK; van Kroonenburgh MJ
J Nucl Med; 1990 Jul; 31(7):1147-55. PubMed ID: 2163439
[TBL] [Abstract][Full Text] [Related]
28. Comparison of radiolabeled octreotide and meta-iodobenzylguanidine (MIBG) scintigraphy in malignant pheochromocytoma.
Tenenbaum F; Lumbroso J; Schlumberger M; Mure A; Plouin PF; Caillou B; Parmentier C
J Nucl Med; 1995 Jan; 36(1):1-6. PubMed ID: 7799058
[TBL] [Abstract][Full Text] [Related]
29. Localization and treatment of familial malignant nonfunctional paraganglioma with iodine-131 MIBG: report of two cases.
Khafagi F; Egerton-Vernon J; van Doorn T; Foster W; McPhee IB; Allison RW
J Nucl Med; 1987 Apr; 28(4):528-31. PubMed ID: 2437268
[TBL] [Abstract][Full Text] [Related]
30. Comparison of In-111 pentetreotide, Tc-99m (V)DMSA and I-123 mlBG scintimaging in neural crest tumors.
Limouris GS; Giannakopoulos V; Stavraka A; Toubanakis N; Vlahos L
Anticancer Res; 1997; 17(3B):1589-92. PubMed ID: 9179199
[TBL] [Abstract][Full Text] [Related]
31. Carcinoid tumors: CT and I-131 meta-iodo-benzylguanidine scintigraphy.
Adolph JM; Kimmig BN; Georgi P; zum Winkel K
Radiology; 1987 Jul; 164(1):199-203. PubMed ID: 3588904
[TBL] [Abstract][Full Text] [Related]
32. Utility of thallium-201 and iodine-123 metaiodobenzylguanidine in the scintigraphic detection of neuroendocrine neoplasia.
Montravers F; Coutris G; Sarda L; Mensch B; Talbot JN
Eur J Nucl Med; 1993 Nov; 20(11):1070-7. PubMed ID: 8287875
[TBL] [Abstract][Full Text] [Related]
33. Usefulness of 123I-metaiodobenzylguanidine (MIBG) scintiscan in the diagnosis of juxta-adrenal schwannoma.
Tommaselli AP; Valentino R; Rossi R; Savastano S; Luciano A; Battista C; Troncone G; Lombardi G
J Clin Endocrinol Metab; 1996 Feb; 81(2):843-6. PubMed ID: 8636313
[TBL] [Abstract][Full Text] [Related]
34. [Contribution of 131I MIBG scintigraphy in the diagnosis of carcinoid tumors of the digestive tract. Experience of 14 cases].
Siproudhis L; Lescouarc'h J; Bretagne JF; Bourguet P; Raoul JL; Etienne PL; Herry JY; Gosselin M
Gastroenterol Clin Biol; 1991; 15(11):789-93. PubMed ID: 1769467
[TBL] [Abstract][Full Text] [Related]
35. Limitations of 131I-MIBG scintigraphy in locating pheochromocytomas.
Gough IR; Thompson NW; Shapiro B; Sisson JC
Surgery; 1985 Jul; 98(1):115-20. PubMed ID: 2861667
[TBL] [Abstract][Full Text] [Related]
36. Detection and treatment of pheochromocytomas and paragangliomas: current standing of MIBG scintigraphy and future role of PET imaging.
Havekes B; Lai EW; Corssmit EP; Romijn JA; Timmers HJ; Pacak K
Q J Nucl Med Mol Imaging; 2008 Dec; 52(4):419-29. PubMed ID: 19088695
[TBL] [Abstract][Full Text] [Related]
37. Poor results with technetium-99m (V) DMS and iodine-131 MIBG in the imaging of medullary thyroid carcinoma.
Hilditch TE; Connell JM; Elliot AT; Murray T; Reed NS
J Nucl Med; 1986 Jul; 27(7):1150-3. PubMed ID: 3014086
[TBL] [Abstract][Full Text] [Related]
38. Thyroid uptake of MIBG in Sipple's syndrome.
Perdrisot R; Rohmer V; Lejeune JJ; Bigorgne JC; Jallet P
Eur J Nucl Med; 1988; 14(1):37-8. PubMed ID: 2898364
[TBL] [Abstract][Full Text] [Related]
39. Specificity of radioiodinated MIBG for neural crest tumors in childhood.
Leung A; Shapiro B; Hattner R; Kim E; de Kraker J; Ghazzar N; Hartmann O; Hoefnagel CA; Jamadar DA; Kloos R; Lizotte P; Lumbroso J; Rufini V; Shulkin BL; Sisson JC; Thein A; Troncone L
J Nucl Med; 1997 Sep; 38(9):1352-7. PubMed ID: 9293786
[TBL] [Abstract][Full Text] [Related]
40. [Diagnosis of extra-adrenal paragangliomas by 131I-MIBG scintigraphy].
Yoshikawa T; Inaba S; Nagai T; Terai T; Ishimaru O; Yamaguchi J; Tsukamoto E; Furudate M
Rinsho Hoshasen; 1988 Oct; 33(10):1151-4. PubMed ID: 2850374
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
